NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I think the 10/31 loan NWBO received potentially covers this time frame you arrived at, assuming we had an Oct 24/25 CHM meeting.

“5. Implications for DCVax-L
So, what does it mean for DCVax-L? DCVax-L's MAA was validated on 1/24/24. That means that it made the 1/29/24 deadline for the 4/25/24 CHM meeting; if that was the case, then its second CHM meeting would be taking place today (aka October 24) (or tomorrow).

Based on recent MHRA performance, that would imply approval as early as 3 weeks from now: 11/14/24. Based on MHRA's performance over the past year, its backlog should be gone before the end of January, meaning that DCVAX-L's approval should come before that time. That's the basis for this prediction: DCVax-L approval between 11/14/24 and 1/31/25.”